The Novel Diketopiperazine Derivative, Compound 5-3, Selectively Inhibited the Proliferation of FLT3-ITD Mutant Acute Myeloid Leukemia (AML) Cells

QR Code

The Novel Diketopiperazine Derivative, Compound 5-3, Selectively Inhibited the Proliferation of FLT3-ITD Mutant Acute Myeloid Leukemia (AML) Cells

The internal tandem duplication mutation of FMS-like tyrosine kinase 3 (FLT3-ITD) is associated with high recurrence and mortality rates in acute myeloid leukemia (AML), making it a critical target for anti-AML therapies. Plinabulin is a diketopiperazines derivative that exhibits extensive anti-canc...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shijie Bi, Yating Cao, Shiyuan Fang, Yanyan Chu, Zixuan Zhang, Meng Li, Rilei Yu, Jinbo Yang, Yu Tang, Peiju Qiu
Format:	Article
Language:	English
Published:	MDPI AG 2025-07-01
Series:	Marine Drugs
Subjects:	acute myeloid leukemia FLT3-ITD mutation diketopiperazine tubulin
Online Access:	https://www.mdpi.com/1660-3397/23/7/289
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparison of fragment analysis and PCR electrophoresis methods for the detection of FLT3‑ITD mutations in patients with acute myeloid leukemia
by: I. E. Maslyukova, et al.
Published: (2022-11-01)

FLT3-ITD promotes immune checkpoint CD80 via ROS elevation in acute myeloid leukemia
by: Libo Yan, et al.
Published: (2025-07-01)

Sitravatinib combined with venetoclax exerts effective synergy to eliminate acute myeloid leukemia cells with FLT3-ITD mutations
by: Jie Yang, et al.
Published: (2025-09-01)

Recurrent Hyperbilirubinemia with Midostaurin during Consolidation in a Patient of AML with FLT3 Mutation and Review of Literature for Alternative Maintenance Strategy
by: Deepak Kumar Shukla, et al.
Published: (2025-08-01)

Targeted therapy of newly diagnosed <i>FLT3</i>-mutated acute myeloid leukemia. A single-center ambispective cohort study
by: N. K. Pastukhov, et al.
Published: (2025-03-01)

Isolation and Identification of <i>Cis-</i>2,5-Diketopiperazine from a Novel <i>Bacillus</i> Strain and Synthesis of Its Four Stereoisomers
by: Alan M. C. Obled, et al.
Published: (2025-05-01)

Development and preclinical characterization of AMG 329: a human antibody neutralizing FLT3 ligand
by: Annie Lau-Kilby, et al.
Published: (2025-12-01)

Клинико-гематологическая и молекулярно-генетическая гетерогенность острых миелоидных лейкозов с экспрессией CD7 на бластных клетках
by: С. В. Грицаев, et al.
Published: (2013-10-01)

LOW DOSE CYTARABINE PLUS SORAFENIB IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA
by: Tural Mahmudov
Published: (2025-07-01)

Analysis of incidence and prognostic significance <i>FLT3, c-KIT</i> and <i>NPM1</i> genes mutation in children with acute myeloid leukemia
by: L. V. Guk, et al.
Published: (2022-11-01)

Effectorless Fc-fusion improves FLT3L drug-like properties for cancer immunotherapy combinationsResearch in context
by: Jérémie Decalf, et al.
Published: (2025-08-01)

Deep Dive into Targeted Therapies: Understanding IDH1-Mutant AML Treatments [Podcast]
by: Zeidan AM, et al.
Published: (2025-07-01)

Impact of parity and pre-pregnancy BMI on second-trimester sFlt-1 and PlGF levels in normotensive pregnancies
by: Motoaki Kinugawa, et al.
Published: (2025-12-01)

VEGF-R1/Flt-1 Receptor as a Characteristic of the Angiogenic Phenotype of Uveal Melanoma
by: V. G. Likhvantseva, et al.
Published: (2021-12-01)

Predictive value of initial involvement and early response assessment using positron‑emission tomography with 18F‑FLT in patients with non‑Hodgkin lymphoma
by: Yu. N. Likar, et al.
Published: (2014-07-01)

Mutations in the “hot spots” of the <i>FLT3</i>, <i>NPM1</i>, <i>IDH1</i>, <i>IDH2</i> and <i>DNMT3A</i> genes in acute myeloid leukemia
by: E. N. Voropaeva, et al.
Published: (2025-03-01)

Clinical and genetic characteristics of type 3 lissencephaly caused by a mutation in the TUBA1A gene (OMIM: 611603)
by: D. M. Guseva, et al.
Published: (2021-04-01)

Use of [18F]FLT/PET for assessing the tumor evolution and monitoring the antitumor activity of rosmarinic acid in a mouse 4T1 breast tumor model
by: Jousie Michel Pereira, et al.
Published: (2023-09-01)

Serum sFlt-1/PlGF ratio combined with ANXA2 correlates with adverse pregnancy outcomes in women with suspected preeclampsia
by: YaNuan Chen, et al.
Published: (2025-12-01)

Resistance mutations impair benzimidazole efficacy against Ascaridia galli by altering β-tubulin interactions
by: Jan Clyden Tenorio
Published: (2025-08-01)

A novel thiazole-sulfonamide hybrid molecule as a promising dual tubulin/carbonic anhydrase IX inhibitor with anticancer activity
by: Hussam Elddin Nabeih Khasawneh, et al.
Published: (2025-06-01)

Real-World Efficacy and Safety of Gemtuzumab Ozogamycin (GO) and 3 + 7 regimen in fit newly diagnosed Acute Myeloid Leukemia (AML) patients. A Retrospective multicenter study of “Rete Ematologica Pugliese” (REP)
by: M. Dargenio, et al.
Published: (2025-01-01)

MicroRNA-dependent mechanisms of taxane resistance in breast cancer
by: V. S. Apollonova, et al.
Published: (2022-12-01)

A Multi-Well Method for the CD138 and AML/MDS FISH Testing of Multiple Biomarkers on a Single Slide in Multiple Myeloma and AML/MDS Patients
by: Frank Tambini, et al.
Published: (2025-06-01)

Gilteritinib
by: Harini Raghunathan, et al.

Risk factors for length of stay and charge per day differ between older and younger hospitalized patients with AML
by: Anita J. Kumar, et al.
Published: (2018-06-01)

Genetic landscape of acute myeloid leukemias with leukocytosis
by: K. A. Pekhova, et al.
Published: (2023-09-01)

A Case Report of Influence of Free Tyrosine Kinase/Placental Growth Factor (SFLT-1/PLGF) Ratio Test for Preeclampsia on Clinical Decision Making in Screening Positive Women
by: Polina Vasileva, et al.
Published: (2019-12-01)

Effect of low-energy extracorporeal shock wave on vascular regeneration after spinal cord injury and the recovery of motor function
by: Wang L, et al.
Published: (2016-08-01)

Clinical and biological features of acute myeloid leukemia with MLL gene rearrangements in children and results of therapy according to protocols AML-MM-2000/2006 in the Republic of Belarus
by: Yu. A. Barovskaya, et al.
Published: (2019-01-01)

Protocol AML-MM-2000 treatment results of unfavorable prognostic group in children with acute myeloid leukemia
by: N. P. Kirsanova, et al.
Published: (2022-11-01)

Computational analysis and molecular dynamics of natural anthelmintic compounds from Algerian herbal sources
by: Farouk BOUDOU, et al.
Published: (2025-06-01)

Clinical and genetic characteristics of acute myeloid leukemia with t(8;21) in children and results of therapy according to protocol AML-MM-2000
by: I. I. Kalinina, et al.
Published: (2014-07-01)

<i>Staphylococcus epidermidis</i> in Acute Myeloid Leukemia: A Comparative Genomic Study Against Non-AML Isolates
by: Stephanie McMahon, et al.
Published: (2025-06-01)

Impact of pre-transplant body mass index on outcomes in AML patients aged ≥ 50 years after allogeneic hematopoietic cell transplantation
by: Wenwen Guo, et al.
Published: (2025-07-01)

The Transfer of Information as a Principle of Musical Creation: Between Data and Meaning (I)
by: Sebastian ANDRONE-NAKANISHI
Published: (2025-06-01)

Expression of the cytoskeletal proteins – cytokeratins and beta-III tubulin in human melanoma cell lines from the collection of N. N. Blokhin National Medical Research Center of Oncology
by: T. A. Bogush, et al.
Published: (2023-10-01)

In Silico Identification of Novel Compounds as Anthelmintics Against <i>Haemonchus contortus</i> Through Inhibiting β-Tubulin Isotype 1 and Glutathione S-Transferase
by: Yaqian Jin, et al.
Published: (2025-06-01)

A Point Mutation of the Alpha-Tubulin Gene <i>ClTUA</i> Causes Dominant Dwarf Phenotype in Watermelon (<i>Citrullus lanatus</i>)
by: Ziwei Hu, et al.
Published: (2025-05-01)

FLT3 tyrosine kinase in acute non-lymphoblastic leukemias
by: A. S. Bavykin, et al.
Published: (2022-11-01)